Entry Limiting Agreements for Pharmaceuticals: Pay-to-Delay and Authorized Generic Deals (2015)
Attributed to:
ESRC Centre for Competition Policy 2009 - 2014
funded by
ESRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.2626508
Publication URI: http://dx.doi.org/10.2139/ssrn.2626508
Type: Journal Article/Review
Parent Publication: SSRN Electronic Journal